Concentrix Corp financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Concentrix Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	4,708	4,720	5,587	6,324	7,115	9,619	9,826
Cost of revenue	2,959	3,058	3,618	4,067	4,537	6,170	6,391
Gross profit	1,748	1,662	1,969	2,257	2,578	3,449	3,435
Selling, general and administrative	1,454	1,353	1,397	1,617	1,917	2,853	2,825
Operating income	294	309	572	640	661	596	-918
Interest expense	92.2	48.3	23	70.1	201	322	290
Other non-operating income	2.28	7.45	6.35	34.9	-52.1	24.7	26.3
Pre-tax income	204	268	556	605	408	299	-1,182
Income tax	87.3	103	150	169	94.4	48.1	96.7
Net income to minority interests		0	0	0.59	0	0
Net income	117	165	406	435	314	251	-1,279
EBITDA	434	438	713	787	835	843	-692
EPS, basic	2.27	3.19	7.78	8.34	5.72	3.72	-20.36
EPS, diluted	2.27	3.19	7.70	8.28	5.70	3.71	-20.36
Shares, basic (weighted)	51.6	51.6	51.4	51.4	53.8	65	63
Shares, diluted (weighted)	51.6	51.6	51.9	51.7	54	65.1	63

Balance sheet

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	83.5	153	182	145	295	241	327
Receivables		1,081	1,208	1,390	1,889	1,927	1,999
Other current assets		189	153	218	674	675	758
Total current assets		1,423	1,543	1,754	2,859	2,842	3,085
Property, plant and equipment		452	407	404	749	715	736
Lease right-of-use assets		506	489	473	814	817	857
Goodwill	1,829	1,836	1,814	2,904	5,079	4,987	3,672
Intangible assets		799	656	986	2,805	2,287	1,960
Other non-current assets		620	579	573	929	942	991
Total assets		5,178	5,046	6,670	12,492	11,991	10,761
Accounts payable		141	129	161	244	210	245
Accrued liabilities		420	453	507	731	707	765
Short-term debt		33.8	0	0	2.31	2.52	65.6
Total current liabilities		1,009	968	1,132	2,074	1,996	2,196
Long-term debt		1,111	802	2,224	4,940	4,733	4,573
Lease liabilities		374	354	341	623	626	641
Other non-current liabilities		602	546	512	921	910	951
Total liabilities		2,875	2,426	3,974	8,349	7,952	8,017
Total debt		1,111	802	2,224	4,940	4,733	4,573
Paid-in capital		0	2,356	2,428	3,583	3,684	3,784
Retained earnings		0	392	774	1,024	1,192	-177
Treasury stock			-57.5	-191	-272	-421	-610
Other comprehensive income		-3.81	-70.5	-316	-192	-414	-252
Shareholders' equity	1,470	2,302	2,620	2,696	4,143	4,040	2,744
Total equity	1,470	2,302	2,620	2,696	4,143	4,040	2,744
Total liabilities and equity		5,178	5,046	6,670	12,492	11,991	10,761
Shares outstanding			51.6	51.1	65.7	64.2	61.7

Cash flow statement

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	117	165	406	436	314	251	-1,279
Depreciation and amortization	139	129	140	147	173	247	226
Stock-based compensation	10.4	15.6	36.2	47.1	62.1	96.1	96.4
Deferred income tax	-16.3	-19.9	-25.7	-30.8	-122	-235	-155
Change in receivables	3.65	-124	-139	-53.1	-45.9	-63.9	-23.1
Change in payables	-5	36.6	-4.55	14.6	9.34	-25.8	28.5
Cash from operations	450	508	514	601	678	667	807
Capital expenditures	-111	-171	-149	-140	-181	-239	-234
Acquisitions	-9.43	-5.56	-3.28	-1,698	-1,914	-5.5	-15.9
Cash from investing	-151	-109	-78.7	-1,839	-2,109	-244	-250
Debt issued			0	0	2,137	0	0
Stock issued	0	0	13.7	9.59	7.2	5.03	3.98
Share buybacks	0	0	-25.1	-121	-64	-136	-169
Dividends paid	0	0	-13.1	-53.4	-63.5	-83.8	-89.6
Cash from financing	-340	-335	-402	1,238	1,803	-493	-491
Exchange rate effect	-3.45	9.66	-7	-24.5	-12.4	-17.6	26.4
Net change in cash	-44.4	72.8	26.7	-25.5	359	-86.9	91.5
Free cash flow	339	336	365	461	497	429	572
Interest paid	0	0	20.8	67.6	143	282	300
Income taxes paid	104	76.6	160	144	217	298	270

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to May 31, 2026; growth uses fiscal years. Valuation uses the share price of $27.08 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	34.0%	Gross profit / revenue.
Operating margin	-10.2%	Operating income / revenue.
EBITDA margin	-7.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-12.4%	Pre-tax income / revenue.
Net margin	-13.1%	Net income / revenue.
FCF margin	5.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	7.4%	Cash from operations / revenue.
Return on equity (ROE)	-48.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-12.5%	Net income / average total assets.
Return on invested capital (ROIC)	-12.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	29.0%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.3%	Capital expenditures / revenue.
D&A / revenue	2.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	2.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	15.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	15.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-0.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	15.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	15.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-254.0%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-182.1%	EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y	-609.1%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-648.8%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	20.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	10.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	9.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	33.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	7.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	11.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-32.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	0.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	3.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-10.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	17.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	15.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-3.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	6.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	4.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.18x	Current assets / current liabilities.
Quick ratio	0.87x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.10x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.46x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	37.4%	Total debt / total assets.
Liabilities / assets	74.3%	Total liabilities / total assets.
Net debt	$3.68B	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	-3.58x	Operating income / interest expense.
Working capital	$460.5M	Current assets - current liabilities.
Goodwill and intangibles / assets	51.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$2.70B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.95x	Revenue / average total assets.
Fixed asset turnover	14.1x	Revenue / average property, plant and equipment.
Receivables turnover	5.03x	Revenue / average receivables.
Days sales outstanding	73 days	365 x average receivables / revenue.
Days payables	11 days	365 x average accounts payable / cost of revenue.
Capex / operating cash flow	30.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$21.60	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$164.29	Revenue / diluted weighted shares.
FCF per share	$8.44	Free cash flow / diluted weighted shares.
Operating cash flow per share	$12.22	Cash from operations / diluted weighted shares.
Book value per share	$44.38	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$44.40	Tangible book value / shares outstanding.
Cash per share	$4.20	(Cash + short-term investments) / shares outstanding.
Dividends / FCF	17.8%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	27.4%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.65B	Share price x shares outstanding.
Enterprise value	$5.33B	Market cap + total debt - cash - short-term investments.
P/S	0.17x	Market cap / revenue.
P/B	0.61x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	3.22x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	2.22x	Market cap / cash from operations, when positive.
EV/Sales	0.53x	Enterprise value / revenue.
EV/FCF	10.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	31.1%	Free cash flow / market cap.
Earnings yield	-79.5%	Net income / market cap (the inverse of P/E).
Dividend yield	5.5%	Dividends paid over the period / market cap.
Shareholder yield	14.0%	(Dividends paid + share buybacks) / market cap.

What was Concentrix Corp's revenue in fiscal 2025?

Concentrix Corp reported revenue of $9.83B for fiscal 2025, 2.2% higher than the year before.

Was Concentrix Corp profitable in fiscal 2025?

No. It reported a net loss of $1.28B.

How much free cash flow did Concentrix Corp generate in fiscal 2025?

Cash from operations of $807.0M minus capital expenditures of $234.5M left free cash flow of $572.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Concentrix Corp